Inhibition of morphine tolerance by NMDA receptor antagonists in the formalin test

Brain Research

Volumn 731, Issue 1-2, 1996, Pages 171-181

  Lutfy, Kabirullah ^a   Shen, Ke Zhong ^b,c   Woodward, Richard M ^b   Weber, Eckard ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Acea Pharmaceuticals Inc   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Antinociception; Formalin test; Glycine co agonist site; NMDA receptor; Tolerance

Indexed keywords

2,3 QUINOXALINEDIONE DERIVATIVE; 6,7 DIMETHYL 5 NITRO 2,3 QUINOXALINEDIONE; DIZOCILPINE; FORMALDEHYDE; MESSENGER RNA; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; PHENCYCLIDINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MORPHINE TOLERANCE; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; XENOPUS;

EID: 0030603088     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-8993(96)00469-6     Document Type: Article

References (50)

1. [1] Abbott, F.V., Melzack, R. and Samuel, C., Morphine analgesia in the tail-flick and formalin pain tests is mediated by different neural systems, Exp. Neurol., 75 (1982) 644-651.
2. [2] Balster, R.L., Discriminative stimulus properties of phencyclidine and other NMDA antagonists. In R.A. Glennon, T.U.C. Järbe and J. Frankenheim (Eds.), Drug Discrimination: Applications to Drug Abuse Research, NIDA Res. Monograph Series, 116 (1991) 163-180.
3. [3] Balster, R.L., Mansbach, R.S., Shelton, K.L., Nicholson, K.L., Grech, D.M., Wiley, J.L., Li, H. and Weber, E., Behavioral pharmacology of two novel substituted quinoxalinedione glutamate antagonists, Behav. Pharmacol. 6 (1995) 577-589.
4. [4] Battaglia, G. and Rustioni, A., Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey, J. Comp. Neurol., 277 (1988) 302-312.
5. [5] Bhargava, H.N., Diversity of agents that modify opioid tolerance, physical dependence, abstinence syndrome, and self-administrative behavior, Pharmacol. Rev., 46 (1994) 293-324.
6. [6] Cahausac, P.M.B., Evans, R.H., Hill. R.G., Rodriquez, R.E. and Smith, D.A.S., The behavioural effects of an N-methylaspartate receptor antagonist following application to the lumbar spinal cord of conscious rats, Neuropharmacology, 23 (1984) 719-724.
7. 50) of an enzymatic reaction, Biochem. Pharmacol., 22 (1973) 3099-3108.
8. [8] Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium-thiocyanate phenol-chloroform extraction, Anal. Biochem., 162 (1987) 156-159.
9. [9] Coderre, T.J. and Melzack, R., The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury, J. Neurosci., 12 (1992) 3665-3670.
10. [10] Dickenson, A.H., A cure for wind up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol. Sci., 11 (1990) 307-309.
11. [11] Dickenson, A.H. and Ayder, E., Antagonism at the glycine site on the NMDA receptor reduces spinal nociception in the rat, Neurosci. Lett., 121 (1991) 263-266.
12. [12] Dickenson, A.H. and Sullivan, A.F., Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurones in the rat, Brain Res., 506 (1990) 31-39, 1990.
13. [13] Geoffroy, M., Lambolez, B., Udinate, E., Hamon, B., Crepel, F., Rossier, J. and Kado, R., Reduction of desensitization of a glutamate ionotropic receptor by antagonists. Mol. Pharmacol., 39 (1991) 587-591.
14. [14] Hollman, M. and Heinemann, S., Cloned glutamate receptors, Annu. Rev. Neurosci., 17 (1994) 31-108.
15. [15] Honore, T.G., Davies, S.N., Drejer, J., Fletcher, E.J., Jacobsen, P., Lodge, D. and Nielsen, F.E., Quinoxalinediones: potent competitive non-NMDA glutamate receptor antagonists, Science, 241 (1988) 701-703.
16. [16] Hunskaar, S., Fasmer, O.B. and Hole, K., Formalin test in mice, a useful technique for evaluating mild analgesics, J. Neurosci. Methods, 14 (1985) 69-76.
17. [17] Jackson, A. and Sanger, D.J., Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors?, Psychopharmacology, 96 (1987) 87-92.
18. [18] Keana, J.F.W., Kher, S.M., Cai, S.X., Dinsmore, C.M., Glenn, A.G., Guastella, J., Huang, J.-C., Ilyin, V., Lü, Y., Mouser, P.L., Woodward, R.M. and Weber, E., Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-dione: Antagonists of N-methyl-D-aspartate (NMDA) receptor glycine sites and non-NMDA glutamate receptors, J. Med. Chem., 38 (1995) 4367-4379.
19. [19] Kiskin, N.L. Krishtal, O.A. and Tsydrenko, A.Y., Excitatory amino acid receptors in hippocampal neurons: kainate fails to desensitize them, Neurosci. Lett., 63 (1990) 255-266.
20. [20] Koek, W. and Colpaert, F.C., Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects, J. Pharmacol. Exp. Ther., 252 (1990) 349-357.
21. [21] Kolesnikov, Y.A., Maccechini, M.-L. and Pasternak, G.W., 1-Aminocyclopropane carboxylic acid (ACPC) prevents mu and delta opioid tolerance, Life Sci., 55 (1994) 1393-1398.
22. [22] Kornetsky, C. and Bain, G., Morphine: single-dose tolerance, Science, 162 (1968) 1011-1012.
23. [23] Leff, P. and Dougall, I.G., Further concerns over Cheng-Prusoff analysis, Trends Pharmacol. Sci., 14 (1993) 110-112.
24. [24] Leonard, J.P. and Kelso, S.R., Apparent desensitization of NMDA responses in Xenopus oocytes involves calcium-dependent chloride current, Neuron, 2 (1990) 553-560.
25. [25] Lester, R.A.J., Quarum, M.L., Parker, J.D., Weber, E. and Jahr, C.E., Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the N-methyl-D-aspartate receptor associated glycine binding site, Mol. Pharmacol., 35 (1989) 565-570.
26. [26] Litchfield, J.T. and Wilcoxon, F., A simplified method of dose-effects experiments, J. Pharmacol. Exp. Ther., 96 (1949) 99-113.
27. [27] Lutfy, K., Hurlbut, D. and Weber, E., Blockade of morphine-induced analgesia and tolerance in mice by MK-801, Brain Res., 616 (1993) 83-88.
28. [28] Lutfy, K., Shen, K.-Z., Kwon, I.-K., Cai, S.X., Woodward, R.M., Keana, J.F.W. and Weber, E., Blockade of morphine tolerance by ACEA-1328, a novel NMDA receptor/glycine site antagonist, Eur. J. Pharmacol., 273 (1995) 187-189.
29. [29] Manzoni, O., Fagni, L., Pin, J.-P., Rassendren, F., Poulat, F., Sladeczek, F. and Bockaert, J., (trans)-1-Amino-cyclopentyl-1,3-dicarboxylate stimulates quisqualate phosphoinositide-coupled receptors but not ionotropic glutamate receptors in striatal neurons and Xenopus oocytes, Mol. Pharmacol., 38 (1990) 1-6.
30. [30] Marek, P., Ben-Eliyahu, S., Gold, M. and Liebeskind, J.C., Excitatory amino acid antagonists (kynurenic acid and MK-801) attenuate the development of morphine tolerance in the rat, Brain Res., 547 (1991) 77-81.
31. [31] Millan, M.J. and Seguin, L., (-)-HA-966, a partial agonist at the glycine site coupled to NMDA receptors, blocks formalin-induced pain in mice, Eur. J. Pharmacol., 238 (1993) 445-447.
32. [32] Miledi, R. and Parker, I., Chloride current induced by injection of calcium in Xenopus oocytes, J. Physiol. (London), 157 (1984) 173-183.
33. [33] Näsström, J., Karlsson, U. and Post, C., Antinociceptive actions of different classes of excitatory amino acid receptor antagonists in mice, Eur. J. Pharmacol., 212 (1992) 21-29.
34. [34] Randle, J.C.R., Guet, T., Bobichon, C., Moreau, C., Curutchet, P., Lambolez, B., Prado De Carvalho, L., Cordi, A, and Lepagnol, J.M., Quinoxaline derivatives: structure-activity relationships and physiological implications of inhibition of N-methyl-D-aspartate and non-N-methyl-D-aspartate receptor-mediated currents and synaptic potentials, Mol. Pharmacol., 41 (1992) 337-345.
35. [35] Rosland, J.H., Hunskaar, S. and Hole, K., The effect of diazepam on nociception in mice, Pharmacol. Toxicol., 61 (1987) 111-115.
36. [36] Ryan, S.M., Watkins, L.R., Mayer, D.J. and Maier, S.F., Spinal pain suppression mechanisms may differ for phasic and tonic pain, Brain Res., 334 (1985) 172-175.
37. [37] Schoepp, D.D. and Conn, P.J., Metabotropic glutamate receptors in brain function and pathology, Trends Pharmacol. Sci., 14 (1993) 13-20.
38. [38] Skilling, S.R., Smullin, D.H. and Larson, A.A., Extracellular amino acid concentrations in the dorsal spinal cord of freely moving rats following veratridine and nociceptive stimulation, J. Neurochem., 51 (1988) 127-132.
39. [39] Swartz, K.J., Koroshetz, W.J., Rees, A.H. and Huettner, J.E., Competitive antagonism of glutamate receptor channel by substituted benzazepines in cultured cortical neurons, Mol. Pharmacol., 41 (1942) 1130-1141.
40. [40] Tallarida, R.J. and Murray, R.B., Manual of Pharmacologic Calculations with Computer Programs, Springer-Verlag, New York, 1987.
41. [41] Tiseo, P.J. and Inturrisi, C.E., Attenuation and reversal of morphine tolerance by the competitive N-methyl-D-aspartate receptor antagonist, LY274614, J. Pharmacol. Exp. Ther., 264 (1993) 1090-1096.
42. [42] Trickelbank, M.D., Singh, L., Oles, R.J., Preston, C. and Iversen, S., The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor, Eur. J. Pharmacol., 167 (1989) 127-135.
43. [43] Trujillo, K.A. and Akil, H., Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801, Science, 251 (1991) 85-87.
44. [44] Vaccarino, A.L., Marek, P., Kest, B., Weber, E., Keana, J.F.W. and Liebeskind, J.C., NMDA receptor antagonists, MK-801 and ACEA-1011, prevent the development of tonic pain following subcutaneous formalin, Brain Res., 615 (1993) 331-334.
45. [45] Way, E.L., Loh, H.H. and Shen, F., Simultaneous quantitative assessment of morphine tolerance and physical dependence, J. Pharmacol. Exp. Ther., 167 (1969) 1-8.
46. + RNA from mammalian brain and retina. Mol. Pharmacol., 41 (1992) 89-103.
47. [47] Woodward, R.M., Huettner, J., Guastella, J., Keana, J.F.W. and Weber, E., In vitro pharmacology of ACEA-1021 and ACEA-1031: Systemically active quinoxalinedione with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites, Mol. Pharmacol., 47 (1995) 568-581.
48. [48] Yamamoto, T. and Yaksh, T.L., Comparison of the antinociceptive effects of pre-and posttreatment with intrathecal morphine and MK801. an NMDA antagonist, on the formalin test in the rat, Anesthesiology, 77 (1991) 757-765.
49. [49] Yoburn, B.C., Sierra, V. and Lutfy, K., Chronic opioid antagonist treatment: assessment of receptor upregulation, Eur. J. Pharmacol., 170 (1989) 193-200.
50. [50] Yoneda, Y. and Ogita, K., Abolition of an NMDA-mediated response by a specific glycine antagonist, 6,7-dichloroquinoxaline-2,3-dione (DCQX), Biochem. Biophys. Res. Commun., 164 (1989) 841-849.